Senior Manager, HCP Marketing Strategy, Type 1 Diabetes (T1D)
Insulet Corporation is one of the fastest growing medical device companies, thanks to the global success of the Omnipod Insulin Management System in reducing the daily burden for people living with diabetes.
The Senior Manager, HCP Marketing Strategy, Type 1 Diabetes (T1D) is responsible for developing the US strategy and specific plans to drive confidence and willingness to prescribe with endocrinologists, pediatric endocrinologists, and other HCPs serving patients with T1D. This individual plays a pivotal role as we capitalize on our market leadership to drive category penetration in T1D and develop the market for broader HCP adoption and practice utilization.
Responsibilities :
Education and Experience :
Minimum Qualifications
Preferred
Skills & Competencies :
Compensation & Benefits : For U.S.-based positions only, the annual base salary range for this role is $132,975.00 - $199,462.50. This position may also be eligible for incentive compensation. We offer a comprehensive benefits package, including : medical, dental, and vision insurance; 401(k) with company match; paid time off (PTO); and additional employee wellness programs.
Application Details : This job posting will remain open until the position is filled. To apply, please visit the Insulet Careers site and submit your application online. Actual pay depends on skills, experience, and education.
Insulet Corporation (NASDAQ : PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
Manager Marketing Strategy • Acton, MA, US